Stratatech Corporation
Industry
- Medical Devices
- Biomaterials
- Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
Latest on Stratatech Corporation
The US FDA approved six novel agents over the first three weeks of May, representing the work of six different review different divisions. The new approvals account for a little more than a quarter of
Orphan drugs account for about one-third of the 41 novel approvals granted by the FDA’s Center for Drug Evaluation and Research so far in 2021, a ratio that is replicated in the center’s three most re
A topical burn treatment from Mallinckrodt plc division Stratatech Corporation has been approved by the US Food and Drug Administration. StrataGraft is indicated to treat adults with thermal burns
Mallinckrodt PLC 's StrataGraft – a regenerative skin tissue therapy – appears closer to reaching the market after a long development road. The company announced on 9 June that it completed a rolling